Commentary: What is the value of a case report for creating medical evidence at times of prospective randomized trials?

J Thorac Cardiovasc Surg. 2020 Jan;159(1):e51-e52. doi: 10.1016/j.jtcvs.2019.06.075. Epub 2019 Jul 18.

Authors

Torsten Doenst¹, Axel Haverich²

Affiliations

¹ Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich-Schiller-University of Jena, Jena, Germany. Electronic address: doenst@med.uni-jena.de.
² Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.

PMID: 31444065
DOI: 10.1016/j.jtcvs.2019.06.075

No abstract available

Publication types

Editorial